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ABSTRACT
Pneumonia complicating pregnancy requires a prompt diagnosis and the institution of adequate
supportive and antimicrobial therapy. In a patient with a classic presentation of pneumonia, the
most likely pathogens are Streptococcus pneumoniae and Haemophilus influenzae. In a patient with an
atypical presentation of pneumonia, Mycoplasma pneumoniae and Chlamydia pneumoniae are fre-
quently encountered. In a patient suffering from acquired immunodeficiency syndrome (AIDS),
Pneumocystis carinii is the most frequent pathogen. The antimicrobial therapy, therefore, has to be
tailored to the sensitivity patterns of these pathogens in the community. Hospitalization is recom-
mended for the pregnant patient diagnosed with pneumonia to ensure effective supportive care and
minimize the risk ofpreterm labor and delivery. (C) 1995 Wiley-Liss, Inc.
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the inflammation of alveoli and res-
piratory bronchioles, is a complication of preg-
nancy that to this date is associated with significant
risk to both the mother and the fetus. In spite of
effective antimicrobial therapy, preterm labor and
both maternal and fetal mortality remain signifi-
cant risks, demanding prompt and effective ther-
apy of the condition. Pneumonia can be caused by a
variety of both infectious and noninfectious agents.
Bacteria and viruses are the most frequent and clin-
ically important infectious etiologies, while para-
sitic and fungal pneumonias are usually limited to
immunocompromised hosts. Aspiration remains the
most common noninfectious cause of pneumonia in
clinical practice.
PATHOGENESIS
Pneumonias caused by infectious agents develop
when pathogens gain access to the lower respiratory
tract and succeed in overwhelming the anatomic
and physiologic defenses of the host.
Particles larger than 10 Ixm in diameter are
trapped in the upper airway, while smaller ones are
removed by the ciliated epithelium and phagocy-
tized by the lung macrophages. Both humoral and
cellular immune responses play a role in the pre-
vention and response to pneumonia. The humoral
immune response is mediated by both IgA and IgG
antibodies. IgA antibodies are present in the secre-
tions and IgG antibodies can be found in the alveoli
and the lung parenchyma. The cellular components
of the immune system are more effective once op-
sonization of the antigens has been achieved.
The infiltration of polymorphonuclear leuko-
cytes that occurs when the infection is established
leads to an increase in the volume of alveolar and
interstitial fluids and produces a pattern of density
on chest radiograph that helps in the evaluation of
the pneumonia. Three basic chest radiographic ab-
normalities have been described: 1) "Air-space"
pneumonia is characterized by consolidated lung
areas secondary to the exudate present in the alve-
oli, with relatively uninvolved bronchi leading to
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air bronchograms. 2) "Interstitial" pneumonia is
characterized by the predominant inflammatory re-
sponse in the alveolar septa, increasing the intersti-
tial markings and producing a reticular pattern. 3)
"Bronchopneumonia" occurs when an air-space
pneumonia involves the bronchi themselves lead-
ing to atelectasis and to the absence of air broncho-
grams.
Several predisposing factors to the development
of pneumonia have been identified: 1) Endotra-
cheal tubes and depressed gag or cough reflexes
remove the upper airway’s ability to protect the
lower respiratory tract from colonization. 2) Ante-
cedent viral infections or smoking may compro-
mise the mucociliary escalator. 3) The effectiveness
of alveolar macrophages is compromised by alco-
holism. 4) Anemia or other chronic diseases may
interfere with the host immunologic response. 5)
Clearly, patients that suffer from immunodeficien-
cies or are on immunosuppressive drugs are at an
increased risk.
The obstetrical patient is at particular risk for
aspiration pneumonia. Aspiration pneumonitis is
made more likely by the delay in gastric emptying
and the decrease in tone of the gastroesophageal
sphincter. Aspiration pneumonia is obviously more
common in patients who suffer from clouding of
consciousness from any etiology, including seizures,
alcoholism, or drug overdose, but general anesthe-
sia is the most significant risk factor. The mortality
for aspiration pneumonitis depends on the severity
of the injury, and it is estimated that more than 100
maternal deaths/year can be directly ascribed to this
complication. 1’2
MICROBIOLOGY
Because antimicrobial therapy of pneumonia is best
started prior to the knowledge of final culture re-
sults, the proper empiric antibiotic therapy must be
instituted based on the knowledge of the organisms
that are most likely to produce the specific clinical
presentation of the pneumonia. Different patho-
genic organisms are responsible for the pneumonias
that present with the "classic" vs. the "atypical"
constellation ofsigns and symptoms. "Classic" pneu-
monias have a sudden onset, with fever, chills, and
a productive cough. A chest radiograph generally
shows consolidation of or more lobes. "Atypical"
pneumonia has a slow progression of the condition
over several days, with a nonproductive cough,
low-grade fever, and generalized malaise. The chest
radiograph frequently reveals an interstitial pneu-
monitis.
The most common organism identified in preg-
nant patients with bacterial pneumonia is Strepto-
coccuspneumoniae. In several reports, this organism
is responsible for 30-50% of pneumonias in an-
tepartum patients.
3-5 S. pneumoniae is a gram-posi-
tive encapsulated diplococcus that causes a classic
pneumonia with abrupt onset of fever, chills, rusty
sputum, and pleuritic chest pain. The patient fre-
quently can recall the precise time of the onset of
symptoms. The disease has a very rapid course and
is associated with a chest radiograph revealing air
bronchograms and consolidation. Pleural effusions
are not uncommon. Leukocytosis and an increase in
immature polymorphonuclear cells are the rule.
The lung parenchyma is not destroyed in strepto-
coccal pneumonia. Haemophilus influenzae has been
frequently isolated as well.
3-s It is a gram-negative
coccobacillus that, like the pneumococcus, requires
opsonization to be phagocytized. Destruction of
pulmonary tissue is rare. The chest radiograph
shows air bronchograms and consolidation occur-
ring frequently in the upper lobes of the lungs.
Klebsiellapneumoniae, an encapsulated gram-neg-
ative rod, has been associated with chronic alcohol-
ism. The chest radiograph is significant for consol-
idation and air bronchograms frequently involving
the upper lobes. Because K. pneumoniae is associ-
ated with destruction of lung tissue, cavitation and
abscess formation may occur.
Staphylococcus aureus is a frequent bacterial patho-
gen in patients recovering from viral pneumonia,
especially influenza. Staphylococcal pneumonia has
an abrupt onset and a rapid course. Pleuritic chest
pain and sputum production are the rule. Fre-
quently, pleural effusion and cavitation develop.
Staphylococcal pneumonia may also result from the
hematogenous dissemination ofthe organisms. This
may occur in an intravenous (IV) drug abuser, a
patient with infected endocarditis, or a patient with
a contaminated IV catheter. In such cases, the chest
X-ray reveals multiple infiltrates in both lung
fields. The patient’s condition is usually critical.
Legionella pneumophila produces an influenza-
like syndrome followed by the development of fe-
ver, chills, and a nonproductive cough, generally
over 3-4 days. Headache and sore throat are com-
mon. The organism causes necrosis of the interal-
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veolar septa leading to fibrosis at the resolution of
the disease.
Anaerobic bacteria are usually associated with
aspiration pneumonia. The onset of the disease is
gradual, and it is usually associated with pleural
effusion, cavitation, and putrid sputum.
Acinetobacter, Serratia, and Pseudomonas play a
significant role in immunocompromised patients.
A large inoculum of these organisms is needed to
establish the infection; therefore, they are of partic-
ular concern in intubated or unconscious patients.
As in the case of Staphylococcus aureus pneumonia,
gram-negative organisms may be hematogenously
deposited in the lungs from sources in the abdomen
or in the pelvis or from septic thrombophlebitis
causing a pneumonia involving all lung fields, as
demonstrated on chest X-ray by multiple infiltrates.
Francisella tularensis is a pleomorphic gram-neg-
ative organism that produces a rapid onset of fever,
chills, and a nonproductive cough. It is acquired by
tick bite or exposure to infected animals. The chest
radiograph may show the characteristic oval infil-
trate near the hilus ofthe lung, but more commonly
the infiltrate is a bronchopneumonia with hilar lym-
phadenopathy.
The most common agent responsible for the atyp-
ical pneumonias is Mycoplasma pneumoniae. The
onset is insidious, with a nonproductive cough,
low-grade fever, and mildly elevated white blood
cell (WBC) count in association with a broncho-
pneumonia on chest radiograph, generally very im-
pressive in relation to the mild-to-moderate symp-
toms reported by the patient. In association with
M. pneumoniae infections, bullous myringitis, cer-
vical lymphadenopathy, and skin rashes have been
reported. Approximately 70% of patients with
Mycoplasma pneumonia are cold-agglutinin posi-
tive. The test, however, is not specific, with cold
agglutinins detected in all other pneumonias and
several other infections. Recovery from Mycoplasma
pneumonia occurs 1-2 weeks after the onset of
symptoms.
Chlamydia pneumoniae is another organism that
causes atypical pneumonia. A more severe pneumo-
nia is caused by C. psittaci, acquired by inhalation
of contaminated fecal particles from birds infected
with the organisms. Human-to-human transmis-
sion has been documented but it is rare. Another
pneumonia which affects people working with live-
stock is caused by Coxiella burnettii, frequently caus-
ing splenomegaly in association with atypical pneu-
monia.
Influenza virus (usually type A) is the most com-
mon viral pathogen involved in pneumonia. Sta-
phylococcus aureus or Streptococcus pneumoniae may
complicate the picture by causing a bacterial super-
infection. Adenovirus, measles, and varicella are
other viruses that have been associated with some
frequency with the development of pneumonia.
Varicella pneumonia is a significant complica-
tion of an otherwise benign disease. The chest ra-
diograph reveals a diffused nodular pattern. It de-
velops 3-6 days after the onset of the vesicular
eruption, with cough, dyspnea, hemoptysis, and
pleuritic chest pain. In pregnancy, significant mor-
tality is associated with this complication.
In immunocompromised patients, fungal and
parasitic pneumonias must be kept in the differen-
tial diagnosis. The most common parasitic pneu-
monia is caused by Pneumocystis carinii and it affects
approximately 80% of patients with acquired im-
munodeficienc syndrome (AIDS).
6-8 The patient
reports dyspnea and a nonproductive cough in asso-
ciation with tachycardia and tachypnea. A diffuse
infiltrate on chest X-ray is the norm, but other
patterns (including a normal chest radiograph) have
been described. A high degree of suspicion is
needed to make an early diagnosis in view of the
mildness of symptoms at the onset.
Tuberculosis is another infection that must be
kept in the differential diagnosis of pneumonia,
especially in immunocompromised patients.
9 Mul-
tidrug-resistant tuberculosis outbreaks in recent
months have been associated with high mortality
rates, compelling physicians to reevaluate control
measures, preventive therapy for persons exposed,
and treatment modalities. The Centers for Disease
Control (CDC)1’11 has recently published guide-
lines for dealing with these issues.
Pneumonias caused by fungi are generally very
mild unless dissemination of the disease occurs.
12
Organisms that may cause pneumonia include Coc-
cidioides immit#, Histoplasma capsulatum, and Blas-
tomyces dermatitidis. Cryptococcus neoformans is a rare
cause of pneumonia, generally causing an encepha-
litis.
3
EVALUATION AND THERAPY
The treatment of the pregnant patient with pneu-
monia has to focus on supportive care as well as
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TABLE I. Suggested therapy of pneumonia in pregnancy
First-line therapy Alternatives
"Classic" syndrome
"Atypical" syndrome
Nosocomial
Aspiration (superinfection)
Influenza A
Varicella pneumonia
Broad-spectrum penicillins, cephalosporins, or penicillins with
beta-lactamase inhibitors
Azythromycin
Aminoglycoside plus antipseudomonal penicillin or penicillin with
beta-lactamase inhibitor or third-generation cephalosporins
Aminoglycoside plus clindamycin or penicillin with beta-lactamase
inhibitor
Amantadine or rimantadine plus inhaled ribavirin
Acyclovir
Azythromycin or erythromycin
Erythromycin
Imipenem cilastatin
Imipenem cilastatin
rapid establishment of effective antimicrobial ther-
apy. It is important to secure sputum and blood
specimens for cultures to guide the therapeutic
choices after the initiation of empiric therapy.
A Gram’s stain of the sputum may provide im-
portant information if properly collected and exam-
ined. The sample must be representative of the
secretions in the alveoli and lower bronchial tree;
therefore, if large amounts of epithelial cells are
noted in the specimen, the sample may be contami-
nated with oropharyngeal flora. If polymorphonu-
clear leukocytes are present and very few epithelial
cells are noted, the sample is adequate. If a sputum
sample cannot be obtained, in certain clinical con-
ditions the clinician may opt to obtain such samples
in a more invasive way by transtracheal aspiration,
bronchoscopy, or open-lung biopsy. Such decisions
have to be made on a case-by-case basis, balancing
the risk of the procedure with the importance of the
information that may be obtained by the diagnostic
modality. Blood cultures should be routinely ob-
tained because of their high specificity if positive.
The role of serology is important in the diagnosis of
some of the atypical pneumonias, but frequently
requires paired acute and convalescent titers, thus
limiting their usefulness in the acute setting.
The antibiotic therapy to be instituted is based on
the most likely pathogens and their sensitivity pat-
terns in the community where the pneumonia is
occurring. Clearly, it is important to distinguish
nosocomial vs. community-acquired pneumonia.
Table summarizes some of the recommended
empiric antibiotic therapies in pregnancy. Such
therapy may be modified on the basis of the culture
result and the patient’s response to therapy.
The antibiotic treatment ofcommunity-acquired,
classic-onset pneumonia is generally with broad-
spectrum penicillins or cephalosporins. Erythro-
mycin may be an alternative regimen. If the com-
munity-acquired pneumonia presents with an
atypical syndrome, erythromycin or azythromycin
is currently the drug of choice in the pregnant
patient. If L. pneumophila is suspected, rifampicin
has been recommended in addition to erythromycin
for seriously ill patients.
14,15 Because of the likeli-
hood of Staphylococcus aureus in bacterial superin-
fections after influenza pneumonia, a first-genera-
tion cephalosporin or nafcillin should be used in
this setting. If the pneumonia is hospital acquired,
above all, in an ICU setting, both aerobic and
anaerobic organisms should be considered possible
pathogens. Broad-spectrum antimicrobial therapy
is then of critical importance. A third-generation
cephalosporin in combination with an aminoglyco-
side is a regimen that has been used success-
fully.
16-18 If the patient suffers from aspiration
pneumonia, IV clindamycin in combination with
an aminoglycoside is felt to be superior to penicillin
G, 16-18
Varicella pneumonia should be treated with IV
acyclovir at high doses, i.e., 10 mg/kg q 8 h.
19-22
Influenza pneumonia can be treated with inhaled
ribavirin and, if influenza A is suspected, amanta-
dine or rimantadine at 100 mg p.o. q 12 h.
23 Of
note is that amantadine and rimantadine are terato-
genic at high doses in some animal models; there-
fore, these drugs should be used in pregnancy only
when indicated. It is important to note that influ-
enza vaccination is not contraindicated in pregnant
women and should be encouraged, especially in the
presence of heart, lung, or renal disease. Of critical
importance is the need for supportive care of the
pregnant patient. Specifically, the prevention of
hypoxia by oxygen supplementation and the correc-
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tion of bronchospasm by the use of bronchodilators
are important early steps. We routinely use a pulse
oximeter to monitor the condition of the patient and
provide oxygen supplementation to maintain oxy-
gen saturation of >95%. Mechanical ventilation is
required if respiratory failure develops with PaO2
of <60 mm of mercury or ventilatory failure with
increasing PaCO2 and acidosis. Delivery of the fetus
may be necessary if the maternal cardiovascular and
respiratory functions cannot be properly maintained.
In aspiration pneumonia, the key is prevention.
Neutralization of gastric acid, coupled with intuba-
tion and extubation techniques that minimize the
risk of aspiration, is of crucial importance. A large
portion of the lung damage that occurs in aspiration
pneumonia is secondary to the damage caused by
the pH of the gastric aspirate to the alveolar capil-
lary membrane. It is of rapid onset and may cause
extensive damage. The superior segments of the
lower lobes are most commonly affected if the aspi-
ration occurs when the patient is supine. The use of
steroids or prophylactic antibiotics is controversial,
but there is no debate on the need to start prompt,
effective antibiotic therapy if bacterial superinfec-
tion is suspected. Such a superinfection usually de-
velops 2-3 days after the initial injury. The combi-
nation of a third-generation cephalosporin and
aminoglycoside is recommended. Again, support-
ive therapy including bronchodilators and possible
mechanical ventilation is indispensable.
CONCLUSIONS
Pneumonia in the pregnant woman is a serious
complication that requires aggressive, prompt in-
tervention. Hospitalization is usually required to
ensure the most effective supportive care to the
patient and to minimize the risk to mother and
fetus. The rapid institution of therapy with appro-
priate antimicrobial agents on the basis of the most
likely pathogens involved will provide the best
chance for an uneventful resolution of the infec-
tion. Preventive efforts should be maximized, in-
cluding influenza or pneumococcal vaccination of
patients at high risk for contracting the disease and
all possible measures to prevent nosocomially ac-
quired pneumonia or aspiration pneumonia.
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